Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02272595 · ClinicalTrials.gov registry record
Rational Therapeutics Based on Matched Tumor and Normal Tissue
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 3
- Enrollment target
NCT02272595: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT02272595 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02272595 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The goal of this laboratory research study is to learn if using molecular information (matched therapy) or not using molecular information and having the study doctor choose the therapy based on your past experience are more effective ways to choose the best cancer treatment for you. This is an investigational study. Up to 200 participants will take part in this study. Up to 50 will be enrolled at MD Anderson.
Primary Outcome
Progression-free survival (PFS) of the last therapeutic line (PFS1) before entering into study, with the PFS2 under study treatment. A clinical meaningful improvement is defined as demonstrating a PFS ratio (PFS2/PFS1) of being 1.5 or better.
Interventions
- OTHER Treatment Based on Genetic Mutation
- OTHER Treatment Based on No Genetic Mutation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2014-11-04 |
| Est. Completion | 2022-01-11 |
What the finished NCT02272595 record still lists
NCT02272595 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Treatment Based on Genetic Mutation is the first listed.
NCT02272595 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02272595 about?
NCT02272595 is a clinical study titled "Rational Therapeutics Based on Matched Tumor and Normal Tissue". The goal of this laboratory research study is to learn if using molecular information (matched therapy) or not using molecular information and having the study doctor choose the therapy based on your past experience are more effective ways to choose the best cancer treatment for you. This is an inv...
What is the current status of trial NCT02272595?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2014-11-04. Estimated completion is 2022-01-11.
What interventions are being tested in trial NCT02272595?
The interventions under investigation include: Treatment Based on Genetic Mutation (OTHER), Treatment Based on No Genetic Mutation (OTHER).
Who is sponsoring clinical trial NCT02272595?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI